Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 56, Issue 4, 2011, Pages 771-777

  Kim, Kwon Bok ^a   Seo, Kyung Ah ^a   Kim, Sung Eun ^b,c   Bae, Soo Kyung ^a   Kim, Dong Hyun ^a   Shin, Jae Gook ^a,b  

^a Inje University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Antiepileptic drugs; Human plasma; Liquid chromatography (LC) tandem mass spectrometry (MS MS)

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ACCURACY; ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; ELUTION; EPILEPSY; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ANTICONVULSANTS; CALIBRATION; CARBAMAZEPINE; CHROMATOGRAPHY, LIQUID; DRUG MONITORING; DRUG STABILITY; EPILEPSY; HUMANS; LINEAR MODELS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; VALPROIC ACID;

EID: 84860388858     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.07.019     Document Type: Article

References (20)

1. LaRoche S.M., Helmers S.L. The new antiepileptic drugs. JAMA 2004, 291:605-614.
2. Mula M., Monaco F. Epilep. Disord. 2009, 11:1-9.
3. Breton H., Cociglio M., Bressolle F., Peyriere H., Blayac J.P., Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 828:80-90.
4. Fisher R.S. Emerging antiepileptic drugs. Neurology 1993, 43:S12-S20.
5. Contin M., Balboni M., Callegati E., Candela C., Albani F., Riva R., Baruzzi A. Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2005, 828:113.
6. Contin M., Mohamed S., Candela C., Albani F., Riva R., Baruzzi A., Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2010, 878:461-465.
7. Mandrioli R., Ghedini N., Albani F., Kenndler E., Raggi M.A. Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 783:253-263.
8. Vermeij T.A., Edelbroek P.M. Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 857:40-46.
9. Yoshida T., Imai K., Motohashi S., Hamano S., Sato M. Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. J. Pharm. Biomed. Anal. 2006, 41:1386-1390.
10. Manoj Babu M.K. Simultaneous separation and quantitation of four antiepileptic drugs-a study with potential for use in patient drug level monitoring. J. Pharm. Biomed. Anal. 2004, 34:315-324.
11. Berry D.J., Patsalos P.N. Comparison of topiramate concentrations in plasma and serum by fluorescence polarization immunoassay. Ther. Drug Monit. 2000, 22:460-464.
12. Ma J., Zhu P.L., Xie J.W., Jia Z.P., Yang J.S. Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma. Acta Pharmacol. Sin. 2002, 23:87-91.
13. Gorodischer R., Burtin P., Verjee Z., Hwang P., Koren G. Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting. Ther. Drug Monit. 1997, 19:637-642.
14. Rambeck B., May T.W., Jurgens M.U., Blankenhorn V., Jurges U., Korn-Merker E., Salke-Kellermann A. Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system. Ther. Drug Monit. 1994, 16:608-612.
15. Subramanian M., Birnbaum A.K., Remmel R.P. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther. Drug Monit. 2008, 30:347-356.
16. Dieckhaus C.M., Thompson C.D., Roller S.G., Macdonald T.L. Mechanisms of idiosyncratic drug reactions: the case of felbamate. Chem. Biol. Interact. 2002, 142:99-117.
17. United States Food and Drug Administration US FDA Guidance for Industry/Bioanalytical Method Validation 2001, US FDA, Rockville, MD.
18. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
19. Corso G., D'Apolito O., Paglia G. The accuracy of oxcarbazepine (OXC) quantification by a liquid chromatography/tandem mass spectrometry method is influenced by the ion source fragmentation of its metabolite trans-diol-carbazepine (DHD). Rapid Commun. Mass Spectrom. 2007, 21:269-272.
20. Patsalos P.N., Berry D.J., Bourgeois B.F.D., Cloyd J.C., Glauser T.A., Johannessen S.I., Leppik I.E., Tomson T., Perucca E. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring. ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49:1239-1276.